Live news related to INVENTIVA stock (FR0013233012): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Inventiva announces its participation in four major investor conferences in March 2026. The biopharmaceutical company's management will be present for…
On Tuesday, the biopharmaceutical group Inventiva released its unaudited preliminary results for the fiscal year 2025. The company reported cash and c…
Inventiva announces the participation of its CEO at an investor conference organized by Guggenheim on February 11 and 12, 2026 in New York. This prese…
Jefferies ajuste ce mercredi sa recommandation sur le titre Inventiva.
The stock of Dijon-based biopharmaceutical company Inventiva surged by 6.27% to 6.10 euros this Wednesday, January 28, at midday. The increase is part…
The share of the French biotech company shows a sharp increase this Tuesday morning, crossing the €4.80 mark after closing at €4.41 the previous day. …
Inventiva's stock closed the week at €4.05, marking a 7.58% increase over the last five sessions. This performance significantly exceeds the gains of …
The biopharmaceutical company Inventiva announced that its CEO, Andrew Obenshain, will speak at the 44th annual J.P. Morgan Healthcare Conference, whi…
The biotechnology value ended the Tuesday, December 9 session at 3.64 euros, up 4% from the previous closing price of 3.50 euros. This rebound occurre…
French biotech Inventiva ended the Wednesday morning session on December 3 with a sharp decline to 3.45 euros, down 5.87% from the previous day's clos…
